Development code · Neuroactive Steroid
GlyphAllo
GlyphAllo is a development code for GlyphAllo (SPT-300), developed by Seaport Therapeutics, Inc..
- Status
- Phase 2 for Major depressive disorder
- Mechanism
- GABA-A receptor PAM
- Developer
- Seaport Therapeutics, Inc.
Programs
- GlyphAllo (SPT-300) for Major depressive disorderPhase 2Recruiting
Also known as
- SPT-300